Study of Erenumab (AMG 334) in Women With Hot Flashes
NCT01890109
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
103
Enrollment
INDUSTRY
Sponsor class
Conditions
Vasomotor Symptoms; Hot Flashes
Interventions
BIOLOGICAL:
Erenumab
DRUG:
Placebo
Sponsor
Amgen